Occult metastases in sentinel nodes of 200 patients with operable breast cancer

被引:56
作者
Dowlatshahi, K
Fan, M
Anderson, JM
Bloom, KJ
机构
[1] Rush Presbyterian St Lukes Med Ctr, Dept Gen Surg, Chicago, IL 60612 USA
[2] Rush Presbyterian St Lukes Med Ctr, Dept Pathol, Chicago, IL 60612 USA
关键词
breast carcinoma; sentinel nodes; occult metastases; serial sectioning; cytokeratin staining;
D O I
10.1245/aso.2001.8.8.675
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Up to 30% of patients with operable breast cancer and negative regional lymph nodes experience disease recurrence within 10 years. Serial sectioning and immunohistochemical staining of these nodes have revealed 9% to 30% occult metastases. Methods: Sentinel nodes from 200 patients with T1 and T2 invasive breast carcinoma were step-sectioned at 2- to 3-mm intervals, fixed in 10% formalin, and embedded in paraffin. Sections were taken from the face of the blocks and stained with hematoxylin and eosin (H&E). The blocks were then cut completely, and sections at .25-mm. intervals were stained with cytokeratin and examined. Results: Tumor metastases were found in 34 patients when the sentinel nodes were examined at 2- to 3-mm intervals, and in an additional 51 patients when the nodes were sectioned in their entirety at .25-mm intervals and stained with cytokeratin, bringing the total number of patients with metastases to 85. Of the 51 patients whose metastases were detected by 2- to 3-mm sectioning and cytokeratin staining, 27 had isolated tumor cells and 24 had clusters of innumerable malignant cells, all of which were visualized and confirmed by H&E staining of the adjacent sections. Conclusions: Histologic examination of sentinel nodes of patients with invasive breast cancer sectioned at 2- to 3-mm intervals and stained with H&E significantly underestimates nodal metastases. Sectioning of the entire sentinel nodes at .25-mm intervals and staining with cytokeratin detects metastases as either isolated cells or as clusters.
引用
收藏
页码:675 / 681
页数:7
相关论文
共 35 条
[1]   Lymphatic mapping and sentinel node biopsy in the patient with breast cancer [J].
Albertini, JJ ;
Lyman, GH ;
Cox, C ;
Yeatman, T ;
Balducci, L ;
Ku, NN ;
Shivers, S ;
Berman, C ;
Wells, K ;
Rapaport, D ;
Shons, A ;
Horton, J ;
Greenberg, H ;
Nicosia, S ;
Clark, R ;
Cantor, A ;
Reintgen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (22) :1818-1822
[2]  
[Anonymous], 1997, AJCC CANC STAGING MA
[3]  
Bauer KD, 2000, CLIN CANCER RES, V6, P3552
[4]   Benign transport of breast epithelium into axillary lymph nodes after biopsy [J].
Carter, BA ;
Jensen, RA ;
Simpson, JF ;
Page, DL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (02) :259-265
[5]   Role of immunohistochemical detection of lymph-node metastases in management of breast cancer [J].
Cote, RJ ;
Peterson, HF ;
Chaiwun, B ;
Gelber, RD ;
Goldhirsch, A ;
Castiglione-Gertsch, M ;
Gusterson, B ;
Neville, AM .
LANCET, 1999, 354 (9182) :896-900
[6]   Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer [J].
Cox, CE ;
Pendas, S ;
Cox, JM ;
Joseph, E ;
Shons, AR ;
Yeatman, T ;
Ku, NN ;
Lyman, GH ;
Berman, C ;
Haddad, F ;
Reintgen, DS .
ANNALS OF SURGERY, 1998, 227 (05) :645-653
[7]  
Dowlatshahi K, 1999, CANCER, V86, P990, DOI 10.1002/(SICI)1097-0142(19990915)86:6<990::AID-CNCR14>3.3.CO
[8]  
2-4
[9]  
Dowlatshahi K, 1997, CANCER, V80, P1188, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO
[10]  
2-H